Glaucoma surgery methods and systems

• US 10,195,080 B2
• Filed: 03/29/2017
• Issued: 02/05/2019
• Est. Priority Date: 05/19/2000
• Status: Expired due to Term

• Current Assignee: Michael S. Berlin
• Original Assignee: Michael S. Berlin
• Inventors: Berlin, Michael S.
• Primary Examiner(s): Roane, Aaron
• Application Number:
  US15/473,454
• Publication Number:
  US 20170202708A1
• Time in Patent Office: 678 Days
• Field of Search: 606 6
• CPC Class Codes: A61F 2009/00844 Feedback systems
• CPC Class Codes: A61F 2009/00868 Ciliary muscles or trabecular meshwork
• CPC Class Codes: A61F 2009/00891 Glaucoma
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61F 9/00781 Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment drainage implants in general A61M27/002
• CPC Class Codes: A61F 9/00802 for photoablation

Abstract

Methods and systems are disclosed for creating an aqueous flow pathway in the trabecular meshwork, juxtacanalicular trabecular meshwork and Schlemm'"'"'s canal of an eye for reducing elevated intraocular pressure. Some embodiments described apparatus and methods useful in photoablation of tissues. In some embodiments, a photoablation apparatus is used to perforate a tissue, forming an aperture into a space behind the tissue. Gases formed during a photoablation process can be used to pressurize the space behind the tissue to enhance patency of the space. In some embodiments the tissue is the trabecular meshwork of the eye and a wall of Schlemm'"'"'s canal, and the space behind the tissue is a portion of the lumen of Schlemm'"'"'s canal. In some embodiments, the method is useful in the treatment of glaucoma by improving outflow from the anterior chamber of the eye into Schlemm'"'"'s canal, reducing intraocular pressure.

Claims

1. A method, for treating glaucoma in an eye, the eye comprising an anterior chamber, a Schlemm'"'"'s canal and a trabecular meshwork there between, the method comprising:

inserting a probe into the eye to provide an ab interno approach to the trabecular meshwork and the Schlemm'"'"'s canal, the probe comprising an optical fiber coupled to an optical coherence tomography apparatus;

photoablating ocular tissue at a first treatment site with the probe, resulting in the formation of a first aperture in the ocular tissue, the first aperture extending from the anterior chamber through the trabecular meshwork into the Schlemm'"'"'s canal; and

photoablating the ocular tissue at a second treatment site with the probe, resulting in the formation of a second aperture in the ocular tissue, the second aperture extending from the anterior chamber through the trabecular meshwork into the Schlemm'"'"'s canal;

wherein the photoablating at the first treatment site and the second treatment is monitored with the optical coherence tomography apparatus.

2. The method of claim 1, wherein the probe compresses the trabecular meshwork at the first treatment site and the second treatment site.

3. The method of claim 1, wherein, the optical coherence tomography apparatus is used to identify the Schlemm'"'"'s canal of the eye.

4. The method of claim 1, wherein the probe comprises a second optical fiber to deliver the photoablative light energy to the eye.

5. The method of claim 1, wherein the OCT apparatus comprises a high resolution imaging apparatus.

6. The method of claim 1, wherein the photoablating is performed with a plurality of ultraviolet laser pulses at each of the first treatment site and the second treatment site.

7. The method of claim 1, wherein treatment comprises photoablating ocular tissue at the first treatment site and photoablating ocular tissue at the second treatment site and wherein an intraocular pressure of the eye is decreased after the treatment as compared to before the treatment.

8. The method of claim 1, wherein treatment comprises photoablating ocular tissue at the first treatment site and photoablating ocular tissue at the second treatment site and wherein an intraocular pressure of the eye is decreased by 20% or more after the treatment as compared to before the treatment.

9. The method of claim 1, wherein a number of apertures formed in the ocular tissue between the anterior chamber and the Schlemm'"'"'s canal is more than two, the number of apertures including the first aperture and the second aperture.